174 related articles for article (PubMed ID: 17167875)
1. In diabetes fight, raising cash and keeping trust.
Santora M
N Y Times Web; 2006 Nov; ():A1, B4. PubMed ID: 17167875
[No Abstract] [Full Text] [Related]
2. What's wrong with money in science.
Stossel T; Shaywitz D
Washington Post; 2006 Jul; ():B3. PubMed ID: 16838447
[No Abstract] [Full Text] [Related]
3. Financial conflicts of interest and the NIH.
Steinbrook R
N Engl J Med; 2004 Jan; 350(4):327-30. PubMed ID: 14736923
[No Abstract] [Full Text] [Related]
4. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
5. Unease on industry's role in hypertension debate.
Saul S
N Y Times Web; 2006 May; ():A1, C9. PubMed ID: 16752458
[No Abstract] [Full Text] [Related]
6. Co-operation between patient organisations and the drug industry in Finland.
Hemminki E; Toiviainen HK; Vuorenkoski L
Soc Sci Med; 2010 Apr; 70(8):1171-5. PubMed ID: 20163903
[TBL] [Abstract][Full Text] [Related]
7. Medicine and the pharmaceutical industry.
Baxter P
Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
[No Abstract] [Full Text] [Related]
8. Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretation.
Pollack A; Abelson R
N Y Times Web; 2006 May; ():C1, C5. PubMed ID: 16752456
[No Abstract] [Full Text] [Related]
9. [The influence of the pharmaceutical industry in patient organisations].
Vermeulen M; Bouma J
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2432-4. PubMed ID: 18064861
[TBL] [Abstract][Full Text] [Related]
10. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
11. Conflict of interest, round 2.
Freedman R; Lewis DA; Michels R; Pine DS; Schultz SK; Tamminga C; Patterson SL; McIntyre JS; Goldman HH; Yudofsky SC; Hales RE; Rapaport MH; Hales D; Krajeski J; Kupfer DJ; Badaracco MA; Scully JH
Am J Psychiatry; 2006 Sep; 163(9):1481-3. PubMed ID: 16946167
[No Abstract] [Full Text] [Related]
12. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
Krimsky S
Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
[No Abstract] [Full Text] [Related]
13. Statement from the ILCA Board on PAHO and WHO acceptance of industry funds.
Brooks EC
J Hum Lact; 2013 Aug; 29(3):289-90. PubMed ID: 23748246
[No Abstract] [Full Text] [Related]
14. Exposing drug industry funding of UK patient organisations.
Ozieranski P; Rickard E; Mulinari S
BMJ; 2019 May; 365():l1806. PubMed ID: 31122928
[TBL] [Abstract][Full Text] [Related]
15. Drugs, devices and doctors.
Krugman P
N Y Times Web; 2005 Dec; ():A41. PubMed ID: 16450464
[No Abstract] [Full Text] [Related]
16. College activities and the ethics of advertising.
Ryan C; Walter G; Robertson M
Australas Psychiatry; 2010 Apr; 18(2):101-5. PubMed ID: 20307152
[TBL] [Abstract][Full Text] [Related]
17. Guidance for guidelines.
Steinbrook R
N Engl J Med; 2007 Jan; 356(4):331-3. PubMed ID: 17251529
[No Abstract] [Full Text] [Related]
18. Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey.
Ball DE; Tisocki K; Herxheimer A
BMC Public Health; 2006 Aug; 6():201. PubMed ID: 16887025
[TBL] [Abstract][Full Text] [Related]
19. Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues.
Caulfield T
Health Law Rev; 2005; 13(2-3):114-6. PubMed ID: 16459424
[No Abstract] [Full Text] [Related]
20. Physicians' conflicts of interest.
Stell LK
APA Newsl Philos Med; 2003; 3(1):161-4. PubMed ID: 15115011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
